These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4033350)
1. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Kula NS; Baldessarini RJ; Bromley S; Neumeyer JL Life Sci; 1985 Sep; 37(11):1051-7. PubMed ID: 4033350 [TBL] [Abstract][Full Text] [Related]
2. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat. Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL Neuropharmacology; 1985 May; 24(5):391-9. PubMed ID: 4022264 [TBL] [Abstract][Full Text] [Related]
3. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279 [TBL] [Abstract][Full Text] [Related]
4. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
5. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems. Robertson HA Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944 [TBL] [Abstract][Full Text] [Related]
6. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147 [TBL] [Abstract][Full Text] [Related]
7. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system. Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830 [TBL] [Abstract][Full Text] [Related]
8. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents. Campbell A; Yeghiayan S; Baldessarini RJ; Neumeyer JL Psychopharmacology (Berl); 1991; 103(3):323-9. PubMed ID: 1676180 [TBL] [Abstract][Full Text] [Related]
9. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S; Markstein R J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum. Onali P; Olianas MC Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423 [TBL] [Abstract][Full Text] [Related]
12. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821 [TBL] [Abstract][Full Text] [Related]
13. Reduced dopaminergic binding during aging in the rodent striatum. Severson JA; Finch CE Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174 [TBL] [Abstract][Full Text] [Related]
14. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats. Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376 [TBL] [Abstract][Full Text] [Related]
15. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors. Fuxe K; Fredholm BB; Agnati LF; Corrodi H Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915 [TBL] [Abstract][Full Text] [Related]
18. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
19. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum. Waddington JL; Cross AJ; Longden A; Owen F; Poulter M Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367 [No Abstract] [Full Text] [Related]
20. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine. Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]